drugset / Trial / NCT00060099
SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia
Phase 2
Unknown
Dana-Farber/Brigham and Women's Cancer Center
National Cancer Institute (NCI) · collab
RandomizedDouble-blindTreatment
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of or treat early cancer. SGN-00101 may be effective in preventing the development of cervical cancer in patients with cervical intraepithelial neoplasia. PURPOSE: This randomized phase II trial is studying how well SGN-00101 works in preventing cervical cancer in patients with cervical intraepithelial neoplasia and human papillomavirus.
Timeline
- Start
- 2003-05
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VERPASEP CALTESPEN | Vaccine | — | Subcutaneous |